Live feed08:15:30·581dSECFilingvia QuantisnowAclaris Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Regulation FD Disclosure, Other Events, Financial Statements and ExhibitsByQuantisnow·Wall Street's wire, on your screen.ACRS· Aclaris Therapeutics Inc.Health CareOriginal source
